Leo is an expert at developing new products from an early stage. He was one of the early team members at Accuri Flow Cytometers (acquired for $205 million by BD Biosciences). After the acquisition, he worked at BD to support the Accuri flow cytometer in becoming one of the market-leading platforms. He is also an expert at user-focused product development. Leo has a B.S. in chemistry from the University of Dayton and a Ph.D. in pharmacology from the University of Michigan.